newsfilter
← Latest News
GlobeNewswire·

InflaRx Announces International Nonproprietary Name of "Izicopan" for INF904

JENA, Germany, Dec. 11, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. (NASDAQ:IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced that the World